References
Hilpert K, Ackermann J, Banner DW, Gast A, Gubernator K, Hadvary P, Labler L, Mueller K, Schmid G, Tschopp TB, van de Waterbeemd H (1994) J Med Chem 37:3889
Shuker SB, Hajduk PJ, Meadows RP, Fesik SW (1996) Science 274:1531
Allen KN, Bellamacina CR, Ding X, Jeffery CJ, Mattos C, Petsko GA, Ringe D (1996) J Phys Chem 100(7):2605
Hann MM, Leach AR, Harper G (2001) J Chem Inf Comput Sci 41:856
Fragments 2009 conference organized by the Royal Society of Chemistry Biological and Medicinal Chemistry Group at AstraZeneca, Cheshire, England, March 4–5, 2009
Kuntz ID, Chen K, Sharp K, Kollman P (1999) PNAS 96:9997
Hopkins AL, Groom CR, Alex A (2004) Drug Discovery Today 9:430
Leeson PD, Springthorpe B (2007) Nat Rev Drug Discovery 6:881
Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) J Med Chem 51:3661
Abad-Zapatero C, Metz JT (2005) Drug Discovery Today 10(7):464
Congreve M, Carr R, Murray C, Jhoti H (2003) Drug Discovery Today 8(19):867
Hubbard RE, Chen L, Davis B, Drysdale MJ (2007) Curr Top Med Chem 7:1568
Everts S (2008) Chem Eng News 86(29):15
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O’Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH (2005) Nature 435(7042):677
Petros AM, Dinges J, Augeri DJ, Baumeister SA, Betebenner DA, Bures MG, Elmore SW, Hajduk PJ, Joseph MK, Landis SK, Nettesheim DG, Rosenberg SH, Shen W, Thomas S, Wang X, Zanze I, Zhang H, Fesik SW (2006) J Med Chem 49:656
Vanwetswinkel S, Heetebrij RJ, van Duynhoven J, Hollander JG, Fillipov DV, Hajduk PJ, Siegal G (2005) Chem Biol 12(2):207
Hajduk PJ, Greer J (2007) Nat Rev Drug Discovery 6:211
Carlson HA, Smith RD, Khazanov NA, Kirchhoff PD, Dunbar JB, Benson ML (2008) J Med Chem 51:6432
Hubbard RE, Chen I, Davis B (2007) Curr Opin Drug Discovery Dev 10(3):289
de Kloe GE, Bailey D, Leurs R, de Esch IJP (2009) Drug Discovery Today doi:10.1016/j.drudis.2009.03.009 (in press)
Baines W (2006) Drug Discovery World. Summer:28
The Drug Design Resource sponsored by IOTA Pharmaceuticals http://drugdesignresource.com/index.php. Accessed April 2009
Acknowledgments
I am grateful to Rod Hubbard of Vernalis and Mark Murko of Vertex for giving balanced answers to my many challenging questions and to David Bailey of IOTA Pharmaceuticals [22] for helping me with Table 1. I would also like to thank several people who have given me ideas but wished to remain anonymous.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Warr, W.A. Fragment-based drug discovery. J Comput Aided Mol Des 23, 453–458 (2009). https://doi.org/10.1007/s10822-009-9292-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-009-9292-1